Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours

Acta Oncol. 2010 Aug;49(6):740-56. doi: 10.3109/0284186X.2010.492791.

Abstract

The diagnostic work-up and treatment of patients with neuroendocrine tumours has undergone a major change during the last decade. New diagnostic possibilities and treatment options have been developed. These Nordic guidelines, written by a group with a major interest in the subject, summarises our current view on how to diagnose and treat these patients. The guidelines are meant to be useful in the daily practice for clinicians handling patients with neuroendocrine tumours.

Publication types

  • Practice Guideline
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Algorithms
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers, Tumor / metabolism
  • Chemotherapy, Adjuvant
  • Denmark
  • Finland
  • Gastrointestinal Neoplasms / classification
  • Gastrointestinal Neoplasms / diagnosis*
  • Gastrointestinal Neoplasms / therapy*
  • Humans
  • Neuroendocrine Tumors / classification
  • Neuroendocrine Tumors / diagnosis*
  • Neuroendocrine Tumors / therapy*
  • Norway
  • Pancreatic Neoplasms / classification
  • Pancreatic Neoplasms / diagnosis*
  • Pancreatic Neoplasms / therapy*
  • Radiotherapy, Adjuvant
  • Sweden

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor